Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · IEX Real-Time Price · USD

0.859

-0.027 (-3.00%)

At close: Jul 2, 2024, 4:00 PM

0.835

-0.024 (-2.79%)

After-hours: Jul 2, 2024, 7:25 PM EDT

Tiziana Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Selling, General & Admin	9.87	1.63	13.31	11.2	6.21	Upgrade
Research & Development	8.11	12.96	13.21	5.99	3.71	Upgrade
Other Operating Expenses	0	0	0.86	10.83	0	Upgrade
Operating Expenses	17.98	14.59	27.37	28.03	9.92	Upgrade
Operating Income	-17.98	-14.59	-27.37	-28.03	-9.92	Upgrade
Interest Expense / Income	0	0	0	0.31	0.09	Upgrade
Other Expense / Income	-0.74	0.81	-0.72	-	-	Upgrade
Pretax Income	-17.24	-15.4	-26.66	-28.34	-10.01	Upgrade
Income Tax	0.45	0	-3.24	-2.21	-0.69	Upgrade
Net Income	-17.69	-15.4	-23.42	-26.13	-9.32	Upgrade
Shares Outstanding (Basic)	102	102	97	68	68	Upgrade
Shares Change	-	5.10%	42.41%	0.14%	-2.93%	Upgrade
EPS (Basic)	-0.17	-0.15	-0.24	-0.16	-0.07	Upgrade
EPS (Diluted)	-0.17	-0.15	-0.24	-0.16	-0.07	Upgrade
Free Cash Flow	-15.7	-19.62	-21.78	-11.34	-6.8	Upgrade
Free Cash Flow Per Share	-0.15	-0.19	-0.22	-0.17	-0.10	Upgrade
EBITDA	-17.15	-15.35	-26.52	-27.94	-9.67	Upgrade
Depreciation & Amortization	0.1	0.05	0.14	0.09	0.25	Upgrade
EBIT	-17.24	-15.4	-26.66	-28.03	-9.92	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).